HK1014369A1 - Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides - Google Patents

Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides

Info

Publication number
HK1014369A1
HK1014369A1 HK98115739A HK98115739A HK1014369A1 HK 1014369 A1 HK1014369 A1 HK 1014369A1 HK 98115739 A HK98115739 A HK 98115739A HK 98115739 A HK98115739 A HK 98115739A HK 1014369 A1 HK1014369 A1 HK 1014369A1
Authority
HK
Hong Kong
Prior art keywords
carbon atoms
group
oligonucleotide
atoms
oligonucleotides
Prior art date
Application number
HK98115739A
Other languages
English (en)
Inventor
David S Jones
John P Hachmann
Michael J Conrad
Stephen Coutts
Douglas Alan Livingston
Original Assignee
Jolla Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Pharma filed Critical Jolla Pharma
Publication of HK1014369A1 publication Critical patent/HK1014369A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/12Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20Free hydroxyl or mercaptan
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2408Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of hydroxyalkyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
HK98115739A 1991-07-15 1998-12-24 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides HK1014369A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73105591A 1991-07-15 1991-07-15

Publications (1)

Publication Number Publication Date
HK1014369A1 true HK1014369A1 (en) 1999-09-24

Family

ID=24937868

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115739A HK1014369A1 (en) 1991-07-15 1998-12-24 Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides

Country Status (13)

Country Link
EP (1) EP0523978B1 (ja)
JP (3) JP2899111B2 (ja)
AT (1) ATE179982T1 (ja)
AU (3) AU664184B2 (ja)
CA (1) CA2073846C (ja)
DE (1) DE69229149T2 (ja)
DK (1) DK0523978T3 (ja)
ES (1) ES2131060T3 (ja)
GR (1) GR3030260T3 (ja)
HK (1) HK1014369A1 (ja)
IE (1) IE922292A1 (ja)
PT (1) PT100691B (ja)
WO (1) WO1993002093A1 (ja)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
AU2003200284B2 (en) * 1998-03-27 2006-11-02 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6344330B1 (en) 1998-03-27 2002-02-05 The Regents Of The University Of California Pharmacophore recombination for the identification of small molecule drug lead compounds
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
EP1632496A1 (en) * 1998-06-22 2006-03-08 Affymetrix, Inc. Reagents and methods for solid phase synthesis and display
US6399578B1 (en) 1998-12-09 2002-06-04 La Jolla Pharmaceutical Company Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
US6458953B1 (en) 1998-12-09 2002-10-01 La Jolla Pharmaceutical Company Valency platform molecules comprising carbamate linkages
CN101422614A (zh) 1999-11-28 2009-05-06 拉卓拉药物公司 基于抗体亲和力来治疗狼疮的方法及使用这种方法的筛选方法和组合物
DE10013600A1 (de) * 2000-03-18 2002-01-10 Aventis Res & Tech Gmbh & Co Reaktive Monomere für die Oligonucleotid- und Polynucleotidsynthese, modifizierte Oligonucleotide und Polynucleotiden und ein Verfahren zu deren Herstellung
AU2002345847B2 (en) 2001-06-21 2008-05-29 Dynavax Technologies Corporation Chimeric immunomodulatory compounds and methods of using the same
DE10163836A1 (de) * 2001-12-22 2003-07-10 Friz Biochem Gmbh Multifunktionales Reagenz zur Synthese von thiolmodifizierten Oligomeren
JP4495670B2 (ja) * 2005-12-27 2010-07-07 三井化学株式会社 メルカプトアルキルホスホニウム化合物の製造法
SG10201408401RA (en) 2009-09-16 2015-01-29 Genentech Inc Coiled coil and/or tether containing protein complexes and uses thereof
AR080793A1 (es) 2010-03-26 2012-05-09 Roche Glycart Ag Anticuerpos biespecificos
JP5766296B2 (ja) 2010-12-23 2015-08-19 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft ポリペプチド−ポリヌクレオチド複合体、およびエフェクター成分の標的化された送達におけるその使用
EP2655414B1 (en) 2010-12-23 2018-08-29 Roche Diagniostics GmbH Bispecific binding agent
JP6046049B2 (ja) 2010-12-23 2016-12-14 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 二価結合剤による翻訳後修飾されたポリペプチドの検出
EP2812357B1 (en) 2012-02-10 2020-11-04 F.Hoffmann-La Roche Ag Single-chain antibodies and other heteromultimers
FR2989086B1 (fr) * 2012-04-04 2017-03-24 Centre Nat De La Rech Scient (Cnrs) Composes thiol et leur utilisation pour la synthese d'oligonucleotides modifies
FR2989089B1 (fr) * 2012-04-04 2020-02-07 Etablissement Francais Du Sang Oligonucleotides modifies comprenant des fonctions thiol et leur utilisation pour la detection d'acides nucleiques
CA2871882A1 (en) 2012-06-27 2014-01-03 F. Hoffmann-La Roche Ag Method for making antibody fc-region conjugates comprising at least one binding entity that specifically binds to a target and uses thereof
MX354862B (es) 2012-06-27 2018-03-23 Hoffmann La Roche Método para la producción de entidades dirigidas altamente selectivas hechas a la medida y biespecíficas que contienen dos entidades de unión diferentes.
CA2892672A1 (en) * 2012-12-06 2014-06-12 Merck Sharp & Dohme Corp. Disulfide masked prodrug compositions and methods
CN107001482B (zh) 2014-12-03 2021-06-15 豪夫迈·罗氏有限公司 多特异性抗体
TW202403044A (zh) * 2022-03-28 2024-01-16 美商安彼瑞可股份有限公司 經修飾之寡核苷酸
WO2023192828A2 (en) * 2022-03-28 2023-10-05 Empirico Inc. Compositions and methods for the treatment of angiopoietin like 7 (angptl7) related diseases

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3225063A (en) * 1962-05-21 1965-12-21 Scott Paper Co Organic cyclic carbonates
US4191668A (en) * 1977-02-03 1980-03-04 Scripps Clinic And Research Foundation Induction of immunological tolerance
US4220565A (en) * 1979-01-18 1980-09-02 Scripps Clinic & Research Foundation Immunochemical conjugates: method and composition
US4650675A (en) * 1983-08-18 1987-03-17 The Children's Medical Center Corporation Oligonucleotide conjugates
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
US4575558A (en) * 1984-02-15 1986-03-11 American Hospital Supply Corporation Preparation of optically active 1,3-dioxolane-4-methanol compounds
US4751181A (en) * 1984-12-31 1988-06-14 Duke University Methods and compositions useful in the diagnosis and treatment of autoimmune diseases
WO1987002777A1 (en) * 1985-10-24 1987-05-07 Research Corporation Limited Biochemical reagent
DE3811005A1 (de) * 1988-03-31 1989-10-19 Bayer Ag Thionophosphor(phosphon)saeureamidester
EP0354323A3 (en) * 1988-08-12 1990-06-13 American Cyanamid Company Antidiabetic phosphates
DE3916871A1 (de) * 1989-05-24 1990-11-29 Boehringer Mannheim Gmbh Modifiziertes phosphoramidit-verfahren zur herstellung von modifizierten nukleinsaeuren
EP0478686B1 (en) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
DE3937116A1 (de) * 1989-11-03 1991-05-08 Dainippon Ink & Chemicals Verfahren zur herstellung cyclocarbonathaltiger ester

Also Published As

Publication number Publication date
ATE179982T1 (de) 1999-05-15
CA2073846C (en) 2007-09-18
EP0523978A1 (en) 1993-01-20
ES2131060T3 (es) 1999-07-16
DK0523978T3 (da) 1999-11-01
JP2899111B2 (ja) 1999-06-02
JP3188243B2 (ja) 2001-07-16
JPH11228592A (ja) 1999-08-24
AU4058095A (en) 1996-03-14
WO1993002093A1 (en) 1993-02-04
PT100691A (pt) 1993-10-29
PT100691B (pt) 1999-06-30
GR3030260T3 (en) 1999-08-31
JP3488435B2 (ja) 2004-01-19
AU1968592A (en) 1993-01-21
AU703715B2 (en) 1999-04-01
DE69229149T2 (de) 1999-12-09
AU686911B2 (en) 1998-02-12
AU664184B2 (en) 1995-11-09
CA2073846A1 (en) 1993-01-16
EP0523978B1 (en) 1999-05-12
JP2001302684A (ja) 2001-10-31
DE69229149D1 (de) 1999-06-17
JPH07500576A (ja) 1995-01-19
IE922292A1 (en) 1993-01-27
AU4520297A (en) 1998-02-19

Similar Documents

Publication Publication Date Title
GR3030260T3 (en) Modified phosphorous intermediates for providing functional groups on the 5' end of oligonucleotides
ES2001246A6 (es) Un metodo para producir una composicion polimera liquida
DE69133280D1 (de) Latente Katalysatoren, Härtungsinhibierte Epoxyharzzusammensetzungen und daraus hergestellte Laminate
ES2173305T3 (es) Polimeros heterotelequelicos y procedimientos para su preparacion.
AU8178094A (en) Polyaminated ligands and metal complexes thereof
CO5180568A1 (es) Compuestos farmaceuticos, especialmente mutilinas, composiciones farmaceuticas que los contienen
DK0710676T3 (da) Hærdelige overtrækssammensætninger indeholdende carbamatharpiks og additiver
KR927003693A (ko) 폴리아민-작용성 실란 수지
BR8902616A (pt) Processo para preparacao de polimeros
DE69318628D1 (de) Aus einem Pflanzenöl und einer Zusatzkonditionierung zusammengesetztes Zweitaktzyklusschmiermittel
DE50004630D1 (de) Urethangruppen enthaltende Photoinitiatoren zur kationischen Härtung
ATE113280T1 (de) Eine perfluoralkylgruppe enthaltende verbindung.
MX9304293A (es) Metodo para curar cauchos sin la formacion de nitrosaminas.
DE69822603D1 (de) Thermoplastisches kristallinpolyurethan und verfahren zu deren herstellung
ATE207058T1 (de) Amine derivate, ihre herstellung und anwendung
GB9201274D0 (en) New compounds
BR9804638A (pt) Processo para reduzir o comprimento de cadeia de sulfano de bis-(sililorganil)-polissulfanos.
KR927003687A (ko) 아미드-아민 실란 수지
ATE98277T1 (de) Verfahren zur herstellung von copolyarylensulfiden.
ES8802300A1 (es) Un metodo para preparar derivados de 3-ariloxiazetidincarboxamida
FR2452491A1 (fr) Procede de cyclisation de sulfures
BR8905907A (pt) Processo para a preparacao de um composto
ATE88474T1 (de) Verfahren zur herstellung eines makrolidderivates.
AU555944B2 (en) Phosphorus derivatives of carbamimidothioic esters
TH2442EX (th) อนุพันธ์ของเอโซลิล-เท็ตตระไฮโดร-ฟิวแรน-2-อิลลีดีนมีเธนที่มีกลุ่มแทนที่ต่าง ๆ

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090715